Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
---|
01/10/2002 | CA2413002A1 Novel pyrazinone derivatives |
01/10/2002 | CA2412287A1 Tetrahydropyridino or piperidino heterocyclic derivatives |
01/10/2002 | CA2412270A1 Pyrrole derivatives for treating aids |
01/09/2002 | EP1170289A2 Retroviral protease inhibiting compounds |
01/09/2002 | EP1170288A2 Diphenylureum derivatives and their use as alpha2/5-HT2c antagonists |
01/09/2002 | EP1169338A2 Low-molecular inhibitors of complement proteases |
01/09/2002 | EP1169320A1 Farnesyl transferase inhibitors having a pyrrole structure and process for preparation thereof |
01/09/2002 | EP1169318A1 Prodrugs of thrombin inhibitors |
01/09/2002 | EP1169317A1 Triarylimidazoles |
01/09/2002 | EP1169298A2 Pharmaceutical compounds |
01/09/2002 | EP1169294A2 Pharmaceutical compounds |
01/09/2002 | EP0996617B1 2,4-Dithi(oxo)-pyridin-5-yl compounds bearing a tricyclic substituent useful as P2 purinoceptor antagonists |
01/09/2002 | EP0918768B1 Aromatic amidine derivatives useful as selective thrombin inhibitors |
01/09/2002 | EP0791034B1 Methine and azamethine dyes made from trifluoromethylpyridones |
01/09/2002 | EP0639190B1 Pyridine sulfonyl urea derivatives |
01/09/2002 | EP0607439B1 Nitrogenous heterocyclic compound |
01/09/2002 | CN1330647A 4-alkenyl (and alkynyl) oxindoles as inhibitors of cell cycle protein dependent kinases, in particular CDK2 |
01/09/2002 | CN1330643A IL-5 inhibiting azauracil pyrimidine derivatives |
01/09/2002 | CN1330640A Cyclic hydrazine derivatives as TNF-alpha inhibitors |
01/09/2002 | CN1330638A Substituted benzo (de) isoquinoline-1,3-diones |
01/09/2002 | CN1330636A Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine amide derivatives having 5HT1A receptor activity |
01/09/2002 | CN1330634A Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds |
01/09/2002 | CN1330631A Amide derivatives which are useful as cell factor inhibitors |
01/09/2002 | CN1330072A Intermediate for preparing 1-[halogenarylradical] heterocyclic pesticide compound |
01/09/2002 | CN1077573C Heterocycles useful as neurokinin antagonists |
01/08/2002 | US6337399 Condensation of isoindole with borate group with quinolone carboxylic acid |
01/08/2002 | US6337397 Pyrimidine derivatives and their salts, useful for making benzoxazepine derivatives |
01/08/2002 | US6337344 Anticoagulants and enzyme inhibitors for cardiovascular disorders |
01/08/2002 | US6337340 Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders |
01/08/2002 | US6337339 Methods and compositions for treating infection using optically pure (S)-lomefloxacin |
01/08/2002 | US6337335 Enzyme inhibitors for autoimmune diseases, transplant rejection, grant versus host disease, hyperproliferative disorders and diseases in which cells receive pro-inflammatory signals. |
01/08/2002 | US6337332 Neuropeptide Y receptor antagonists |
01/08/2002 | US6337326 N-aryl-(homopiperazinyl)-cyclohexyl amines |
01/08/2002 | US6337305 Substituted 2-benz(o)ylpyridines, their preparation and their use as herbicides |
01/08/2002 | CA2294614C Omeprazole sodium salt |
01/08/2002 | CA2216100C Process for 2-substituted benzo¬b|thiophene compounds and intermediates thereof |
01/08/2002 | CA2205202C Sulfur-substituted azetidinone compounds useful as hypocholesterolemic agents |
01/08/2002 | CA2150703C Substituted pyrazoles |
01/03/2002 | WO2002000651A2 Factor xa inhibitors |
01/03/2002 | WO2002000650A2 Novel compounds possessing antibacterial, antifungal or antitumor activity |
01/03/2002 | WO2002000647A1 Heteroaryl-phenyl substituted factor xa inhibitors |
01/03/2002 | WO2002000645A1 Indole derivatives useful for the treatment of cns disorders |
01/03/2002 | WO2002000644A1 Guanidine derivatives of quinazoline and quinoline for use in the treatment of autoimmune diseases |
01/03/2002 | WO2002000643A1 Quinophthalone-derivative based crystallization modifiers |
01/03/2002 | WO2002000632A1 Benzodiazepines as inhibitors of hpv e1 helicase |
01/03/2002 | WO2002000631A2 Benzhydryl derivatives |
01/03/2002 | WO2002000626A1 Fused azepine derivatives and their use as antidiuretic agents |
01/03/2002 | WO2002000624A2 Methods and compounds for inhibiting mrp1 |
01/03/2002 | WO2002000623A2 Aryl fused substituted 4-oxy-pyridines |
01/03/2002 | WO2002000622A2 Aminoalcohol derivatives |
01/03/2002 | WO2002000606A1 Biphenyl compound |
01/03/2002 | WO2002000200A1 Novel process for preparing crystalline particles |
01/03/2002 | WO2002000166A2 New compounds useful as antibacterial agents |
01/03/2002 | WO2001062233A3 Adenosine receptor modulators |
01/03/2002 | WO2001054501A3 Herbicidal composition |
01/03/2002 | WO2001051473A8 1,2-diaryl benzimidazoles for treating illnesses associated with a microglia activation |
01/03/2002 | WO2001040184A3 Methods for the syntheses of alfentanil, sufentanil and remifentanil |
01/03/2002 | WO2000061549A3 Pharmaceutical compounds |
01/03/2002 | WO2000050470A3 Catalysts containing n-pyrrolyl substituted nitrogen donors |
01/03/2002 | US20020002183 Benzamides and related inhibitors of factor Xa |
01/03/2002 | US20020002182 Cis-substituted aminocyclopropane derivatives |
01/03/2002 | US20020002174 Serotonin antagonists |
01/03/2002 | US20020002170 Piperidine and piperazine derivatives as inhibitors of the abeta fibril formation |
01/03/2002 | US20020002169 Protein kinase inhibitors |
01/03/2002 | US20020002163 1,4-benzodiazepinones and their uses as CCK antagonists |
01/03/2002 | US20020002162 Synergistic methods and compositions for treating cancer |
01/03/2002 | US20020001566 Pharmaceuticals for the imaging of angiogenic disorders |
01/03/2002 | DE10030375A1 Verwendung von MTP-Inhibitoren zur Senkung von ppTRL Use of MTP inhibitors to reduce ppTRL |
01/03/2002 | DE10029371A1 Heterocyclische Aminoalkylpyridinderivate als Psychopharmaka Heterocyclic Aminoalkylpyridinderivate as psychotropic drugs |
01/03/2002 | DE10027514A1 Liganden von Integrinrezeptoren Ligands of integrin |
01/03/2002 | CA2414512A1 Novel compounds possessing antibacterial, antifungal or antitumor activity |
01/03/2002 | CA2414115A1 Indole derivatives useful for the treatment of cns disorders |
01/03/2002 | CA2413579A1 Methods and compounds for inhibiting mrp1 |
01/03/2002 | CA2412555A1 Fused azepine derivatives and their use as antidiuretic agents |
01/03/2002 | CA2411157A1 Benzodiazepines as inhibitors of hpv e1 helicase |
01/03/2002 | CA2409762A1 Heteroaryl-phenyl substituted factor xa inhibitors |
01/02/2002 | EP1165738A1 Composition and method for bleaching a substrate |
01/02/2002 | EP1165693A2 Squaraine dyes |
01/02/2002 | EP1165557A1 ARYL AND HETEROARYL FUSED AMINOALKYL-IMIDAZOLE DERIVATIVES: SELECTIVE MODULATORS OF GABAa RECEPTORS |
01/02/2002 | EP1165554A1 New endothelin converting enzyme inhibitors, their production and their use |
01/02/2002 | EP1165547A1 Substituted benzoylpyrazoles as herbicides |
01/02/2002 | EP1165546A2 Novel lactam inhibitors of matrix metalloproteinases, tnf-alpha, and aggrecanase |
01/02/2002 | EP1165545A1 Novel compounds |
01/02/2002 | EP1165544A1 Substituted 1,4-dihydroindeno[1,2-c]pyrazoles as inhibitors of tyrosine kinase |
01/02/2002 | EP1165543A1 PROCESS FOR PREPARING S-(R*,S*)] -$g(b) - 1- 1-OXO-3- (4-PIPERIDINYL) PROPYL] -3-PIPERIDINYL] CARBONYL] AMINO] -3- PYRIDINEPROPANOIC ACID AND DERIVATIVES |
01/02/2002 | EP1165542A1 4-substituted quinoline derivatives as nk-3 and/or gaba(a) receptor ligands |
01/02/2002 | EP1165533A2 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
01/02/2002 | EP1165523A1 Neurotrophic substituted pyrimidines |
01/02/2002 | EP1165518A2 Benzimidazole and imidazolopyridine derivatives, their preparation and their use as selective modulators of bradykinin b2 (= bk-2) receptors |
01/02/2002 | EP1165516A2 Heterocyclic urea and related compounds useful as anti-inflammatory agents |
01/02/2002 | EP1165515A1 Pyridine-2,3-dicarboxylic acid diamides |
01/02/2002 | EP1165514A1 3-(anilinomethylene) oxindoles as protein tyrosine kinase and protein serine/threonine kinase inhibitors |
01/02/2002 | EP1165513A1 Indolinone compounds as kinase inhibitors |
01/02/2002 | EP1165512A2 Method for arylating aza-heterocycles with activated aromatic compounds in the presence of cesium carbonate |
01/02/2002 | EP1165510A1 1-arenesulfonyl-2-aryl-pyrrolidine and piperidine derivatives for the treatment of cns disorders |
01/02/2002 | EP1165506A1 Substituted azetidin-2-ones as cysteine protease inhibitors |
01/02/2002 | EP1165505A1 Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds |
01/02/2002 | EP1165500A1 Amide derivatives as inhibitors of matrix metalloproteinases,tnf-alpha,and aggrecanase |
01/02/2002 | EP1165496A1 Substituted aniline compounds |
01/02/2002 | EP1165085A1 Phthalazine derivatives for treating inflammatory diseases |